Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5299)
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
SUH, DAVID JR. — Chief Accounting Officer
Shares
200
Price
$5.00
Total Value
$1.00K
Shares Held After
111,866
% of Holdings
0.2%
Liquidia Corp (LQDA)
Kaseta Michael — CFO and COO
Shares
133,789
Price
$40.24
Total Value
$5.38M
Shares Held After
411,855
% of Holdings
24.5%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
25,000
Price
$40.12
Total Value
$1.00M
Shares Held After
1,516,667
% of Holdings
1.6%
Kiniksa Pharmaceuticals International, plc (KNSA)
Moat Ross — CHIEF OPERATING OFFICER
Shares
1,703
Price
$46.69
Total Value
$79.51K
Shares Held After
12,029
% of Holdings
12.4%
Kiniksa Pharmaceuticals International, plc (KNSA)
Megna Michael R — CHIEF ACCOUNTING OFFICER
Shares
6,625
Price
$46.69
Total Value
$309.32K
Shares Held After
27,418
% of Holdings
19.5%
Twist Bioscience Corp (TWST)
Laponis Adam — Chief Financial Officer
Shares
2,597
Price
$49.89
Total Value
$129.56K
Shares Held After
125,694
% of Holdings
2.0%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
200
Price
$183.00
Total Value
$36.60K
Shares Held After
170,934
% of Holdings
0.1%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
3,000
Price
$182.40
Total Value
$547.19K
Shares Held After
171,134
% of Holdings
1.7%
Nuvalent, Inc. (NUVL)
Pelish Henry E. — Chief Scientific Officer
Shares
900
Price
$105.00
Total Value
$94.50K
Shares Held After
65,604
% of Holdings
1.4%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
3,500
Price
$181.33
Total Value
$634.66K
Shares Held After
174,134
% of Holdings
2.0%
Nuvalent, Inc. (NUVL)
Pelish Henry E. — Chief Scientific Officer
Shares
2,193
Price
$104.27
Total Value
$228.66K
Shares Held After
66,504
% of Holdings
3.2%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
2,500
Price
$180.36
Total Value
$450.89K
Shares Held After
177,634
% of Holdings
1.4%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
291
Price
$183.08
Total Value
$53.28K
Shares Held After
93,800
% of Holdings
0.3%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
1,909
Price
$182.58
Total Value
$348.54K
Shares Held After
94,091
% of Holdings
2.0%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
2,000
Price
$181.40
Total Value
$362.79K
Shares Held After
96,000
% of Holdings
2.0%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
2,000
Price
$180.35
Total Value
$360.69K
Shares Held After
98,000
% of Holdings
2.0%
BELITE BIO, INC (BLTE)
Chen Wan-Shan — Director
Shares
1,100
Price
$180.43
Total Value
$198.47K
Shares Held After
9,096
% of Holdings
10.8%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
10,000
Price
$1.41
Total Value
$14.10K
Shares Held After
13,586,890
% of Holdings
0.1%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
10,000
Price
$1.43
Total Value
$14.30K
Shares Held After
13,576,890
% of Holdings
0.1%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
10,000
Price
$1.43
Total Value
$14.30K
Shares Held After
13,566,890
% of Holdings
0.1%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
5,000
Price
$1.43
Total Value
$7.15K
Shares Held After
13,556,890
% of Holdings
0.0%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
10,000
Price
$1.43
Total Value
$14.30K
Shares Held After
13,551,890
% of Holdings
0.1%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
5,240
Price
$1.43
Total Value
$7.49K
Shares Held After
13,541,890
% of Holdings
0.0%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
10,000
Price
$1.43
Total Value
$14.30K
Shares Held After
13,536,650
% of Holdings
0.1%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
20,000
Price
$1.43
Total Value
$28.60K
Shares Held After
13,526,650
% of Holdings
0.1%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
4,760
Price
$1.44
Total Value
$6.85K
Shares Held After
13,506,650
% of Holdings
0.0%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
10,000
Price
$1.44
Total Value
$14.40K
Shares Held After
13,501,890
% of Holdings
0.1%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
500,000
Price
$1.44
Total Value
$720.00K
Shares Held After
13,491,890
% of Holdings
3.7%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
105,000
Price
$1.46
Total Value
$153.30K
Shares Held After
12,991,890
% of Holdings
0.8%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
886,890
Price
$1.43
Total Value
$1.27M
Shares Held After
12,886,890
% of Holdings
6.9%
MESOBLAST LTD (MESO)
George Gregory — Director
Shares
886,890
Price
$1.43
Total Value
$1.27M
Shares Held After
12,886,890
% of Holdings
6.9%
908 Devices Inc. (MASS)
McCallion Kevin J. — SVP, Products and Production
Shares
5,420
Price
$7.03
Total Value
$38.10K
Shares Held After
44,925
% of Holdings
10.8%
908 Devices Inc. (MASS)
Brown Christopher D. — Director
Shares
7,392
Price
$7.04
Total Value
$52.04K
Shares Held After
963,137
% of Holdings
0.8%
Whitehawk Therapeutics, Inc. (WHWK)
Lennon David James — Director
Shares
14,500
Price
$3.38
Total Value
$49.01K
Shares Held After
518,622
% of Holdings
2.7%
Vor Biopharma Inc. (VOR)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
135,201
Price
$16.59
Total Value
$2.24M
Shares Held After
3,936,436
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
162
Price
$582.30
Total Value
$94.33K
Shares Held After
18,876
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,756
Price
$580.64
Total Value
$1.02M
Shares Held After
19,038
% of Holdings
8.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,224
Price
$579.75
Total Value
$709.61K
Shares Held After
20,794
% of Holdings
5.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,139
Price
$578.52
Total Value
$658.94K
Shares Held After
22,018
% of Holdings
4.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,617
Price
$577.77
Total Value
$934.25K
Shares Held After
23,157
% of Holdings
6.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,586
Price
$576.63
Total Value
$914.53K
Shares Held After
24,774
% of Holdings
6.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,956
Price
$575.53
Total Value
$1.13M
Shares Held After
26,360
% of Holdings
6.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
560
Price
$574.87
Total Value
$321.93K
Shares Held After
28,316
% of Holdings
1.9%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Savitz Ryan — EVP, CFO & CBO
Shares
8,224
Price
$89.84
Total Value
$738.84K
Shares Held After
0
% of Holdings
100.0%
Kymera Therapeutics, Inc. (KYMR)
Goodman Noah — Chief Business Officer
Shares
2,500
Price
$89.00
Total Value
$222.50K
Shares Held After
53,542
% of Holdings
4.5%
Kymera Therapeutics, Inc. (KYMR)
Goodman Noah — Chief Business Officer
Shares
2,670
Price
$87.11
Total Value
$232.59K
Shares Held After
56,042
% of Holdings
4.5%
Kymera Therapeutics, Inc. (KYMR)
Goodman Noah — Chief Business Officer
Shares
3,094
Price
$86.62
Total Value
$268.00K
Shares Held After
58,712
% of Holdings
5.0%
Ginkgo Bioworks Holdings, Inc. (DNA)
Canton Barry — 10% Owner
Shares
13,116
Price
$6.40
Total Value
$83.90K
Shares Held After
338,568
% of Holdings
3.7%
Ginkgo Bioworks Holdings, Inc. (DNA)
Kelly Jason R — Director
Shares
109,767
Price
$6.40
Total Value
$702.18K
Shares Held After
316,483
% of Holdings
25.8%
Ginkgo Bioworks Holdings, Inc. (DNA)
Shetty Reshma P. — Director
Shares
13,116
Price
$6.40
Total Value
$83.90K
Shares Held After
338,568
% of Holdings
3.7%
Showing 451–500 of 5299 transactions (page 10 of 106)